Figure 1.

Global distribution of clinical trials using terms Omics and Cancer. Clinical studies that have omics and cancer as keywords are shown here. Studies in East Asia correspond to 50.46% of clinical trials, European studies correspond to 21.10%, and United States correspond to 11.92% of all clinical trials. Colors indicate the number of studies located in the region, ranging from green (least studies) to red (most studies). Studies with no location are not included in the counts or on the map and studies with multiple locations are included in all corresponding regions.